Preventing physical and chemical degradation of the LABL-Fc-MOGR5, a bifunctional peptide inhibitor, with formulation development approaches.
Saved in:
| Title: | Preventing physical and chemical degradation of the LABL-Fc-MOG |
|---|---|
| Authors: | Xin L; BioDev Department, WuXi Biologics USA, Cranbury, NJ 08512, United States.; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States., Mahadik R; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States., Prorok M; BioDev Department, WuXi Biologics USA, Cranbury, NJ 08512, United States., Rodriguez MS; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States., Chan KQ; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States., Tolbert T; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States., Li Y; BioDev Department, WuXi Biologics USA, Cranbury, NJ 08512, United States., Siahaan TJ; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States. |
| Source: | Antibody therapeutics [Antib Ther] 2026 Feb 24; Vol. 9 (3), pp. 215-229. Date of Electronic Publication: 2026 Feb 24 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 101730822 Publication Model: eCollection Cited Medium: Internet ISSN: 2516-4236 (Electronic) Linking ISSN: 25164236 NLM ISO Abbreviation: Antib Ther Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
